AHA Coding Clinic® for ICD-9 - 1992 Fourth Quarter; New/Revised Codes
Eosinophilia Myalgia Syndrome
Eosinophilia myalgia syndrome (EMS), first recognized in 1989, is a chronic disease that predominantly affects the skin, muscle, and nerves with central nervous, cardiac, and pulmonary system complications. Patients experience a variety of signs and symptoms, including diffuse muscle pain (myalgia) and elevated numbers of eosinophils in the blood (eosinophilia). In some cases patients experience severe pulmonary symptoms (i.e., pneumonia), cardiac symptoms (i.e., arrhythmias, pulmonary hypertension), and, neurologic symptoms (i.e., ascending polyneuropathy). Since EMS is a chronic condition, patients may require treatment for the remainder of their lives. EMS is a result of a contaminant used...
Subscribe or sign in to view the full article.
Article Overview
This article explains eosinophilia myalgia syndrome as a chronic condition with multi-system involvement and reviews its association with contaminated L-tryptophan. It is relevant to coders, compliance staff, and clinicians who need to understand the condition’s general presentation and the related diagnostic reference additions in the ICD-10/ICD coding context as presented by the source.
Why This Topic Matters
EMS can present with broad and sometimes severe systemic findings, so accurate recognition of the condition matters for documentation and code assignment. The article also notes a specific diagnostic code reference and a drug/chemical index addition, making it useful for coding reference and historical classification context.
Article Sections
-
Clinical Overview
Summarizes the condition’s general presentation, body systems that may be affected, and the chronic nature of the syndrome.
-
Cause and Exposure Background
Describes the association with contaminated L-tryptophan and its historical use as a supplement.
-
Coding Reference Notes
Notes the diagnostic coding reference added for the condition and the related drug/chemical index entry mentioned in the article.
What You Will Learn
- The general clinical profile of eosinophilia myalgia syndrome
- How the syndrome is historically associated with contaminated L-tryptophan
- What coding-reference updates are mentioned in connection with the condition
- Why the condition is relevant for documentation and classification awareness
Who Should Read This
- Medical coders
- Coding auditors
- Compliance professionals
- Clinical documentation specialists
- Clinicians reviewing coding-related references
Codes Discussed
Code Ranges Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com